Scientists at the University of Leicester have captured the first detailed "molecular movie" showing DNA being unzipped at the atomic level – revealing how cells begin the crucial process of copying ...

Scientists have captured the first detailed 'molecular movie' showing DNA being unzipped at the atomic level -- revealing how cells begin the crucial process of copying their genetic material.

Mitochondria are the powerhouses in our cells, producing the energy for all vital processes. Using cryo-electron tomography, ...

For the first time, scientists have witnessed the very moment DNA begins to unravel, revealing a necessary molecular event ...

The result is a three-dimensional Fourier, or electron-density, map of the unit cell, which for the first time reveals the general nature of the tertiary structure of a protein molecule.

The fifth-seeded Russian hit 34 winners, including 10 aces, in winning his 17th ATP Tour title but his first since last May at the ATP Masters 1000 in Madrid. He also won the crown in Doha in 2020.

Adenosine is a pleiotropic immunosuppressive substance, produced mainly by the enzymes CD39 and CD73, from extracellular immunogenic ATP. Thus, CD73-rich tumors may experience decreased anti-tumor ...

Tennis fans in the Middle East got to enjoy almost a month of exciting tennis. It all started with the WTA 1000 tournament in Doha, continued by the ATP 500 event in the same city and a WTA 1000 ...

Novak Djokovic is a two-time champion in Qatar. The ATP Qatar Open 2025 is the 33rd edition of the Qatar Open, a men’s tennis tournament to be played on outdoor hard courts. It is part of the ATP Tour ...

On Friday, the No. 5 seed came through a decisive tie-break for the second successive day in Doha to reach his 10th career ATP 500 final. Rublev edged out Felix Auger-Aliassime, winner of two ...

Andy Murray will continue to coach Novak Djokovic at Indian Wells and will also head to the US for the Miami Open in March as the two prepare to work together across the North American Swing and ...

SEP-786 is an oral small molecule agonist of the parathyroid hormone 1 receptor (PTH1R) being developed for the treatment of hypoparathyroidism. Septerna’s decision follows the observation of ...